Patient Guide: Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 8 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06604871
Status: ACTIVE_NOT_RECRUITING
Condition: Type 1 Diabetes
Phase: NA

Where You Can Participate

This study is available at 8 locations across the country.

Top locations include:
  • • Palo Alto, California
  • • San Francisco, California
  • • Aurora, Colorado
  • • And 5 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children - Join Clinical Trial NCTNCT06604871

How to Join This Clinical Trial - NCTNCT06604871

Learn how to participate in this NA trial studying an investigational therapy for Type 1 Diabetes. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Type 1 Diabetes. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Type 1 Diabetes
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06604871 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 8 locations. Find a study site near you:

Clinical Research Site

Palo Alto, California 94304 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94158 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32207 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33612 - United States

Status: Contact for availability

Clinical Research Site

Cleveland, Ohio 44106 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77030 - United States

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Type 1 Diabetes:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships